|
|||||
|
|
Regulatory and logistical issues influencing access to antineoplastic and supportive care medications for children with cancer in developing countries |
|
| Authors: | for The Working Group on Essential Medicines of the Pediatric Oncology in Developing Countries committee of SIOP |
| Abstract: | |
| Keywords: | cancer pharmacology drug access low/middle income countries pediatrics |